- Home
- COYA vs GECC Comparison
COYA vs GECC Comparison
Compare COYA & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.47
Company Overview
Basic Information| Metric | COYA | GECC |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 101.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | COYA | GECC |
|---|---|---|
| Price | $4.47 | $5.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $15.80 | $10.75 |
| AVG Volume (30 Days) | 101.5K | ★ 106.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 22.14% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,554,061.00 | N/A |
| Revenue This Year | $69.95 | $6.15 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $5.40 |
| 52 Week High | $7.75 | $11.45 |
Technical Indicators
Market Signals| Indicator | COYA | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 21.19 |
| Support Level | $4.50 | N/A |
| Resistance Level | $5.21 | $7.16 |
| Average True Range (ATR) | 0.27 | 0.27 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 22.00 | 3.57 |
Price Performance
Historical Comparison COYA
GECC
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.